Takeda Pharmaceutical Co. Ltd. posted a 27.9 percent rise in operating profit for the October-December 2018 period, supported by strong sales of the company’s drugs for bowel disease and multiple myeloma.

AbbVie reported a loss of $1.83 billion for the fourth quarter of 2018. Overall revenues were up for full-year 2018, however, hitting $32.75 billion compared to $28.2 billion in 2017.

Novartis will cut 2,550 jobs in Switzerland and Britain over four years as the Swiss drugmaker strives to boost profits and focus on new medicines.

Teva Pharmaceutical Industries’ board of directors agreed to take a 50 percent pay cut.

Dublin, Ireland-based Perrigo Company plc (PRGO) announced today that it will take a number of actions, including layoffs, to increase profitability and help fend off a hostile takeover by Canonsburg, Penn. and UK-based Mylan N.V.   The company plans to consolidate its global supply chain, operations and procurement management activities into a single global center […]